Monsanto ordered to pay $289 million in world’s first Roundup cancer trial

(Reuters) – A California jury on Friday found Monsanto liable in a lawsuit filed by a man who alleged the company’s glyphosate-based weed-killers, including Roundup, caused his cancer and ordered the company to pay $289 million in damages.

The case of school groundskeeper Dewayne Johnson was the first lawsuit to go to trial alleging glyphosate causes cancer. Monsanto, a unit of Bayer AG following a $62.5 billion acquisition by the German conglomerate, faces more than 5,000 similar lawsuits across the United States.

The jury at San Francisco’s Superior Court of California deliberated for three days before finding that Monsanto had failed to warn Johnson and other consumers of the cancer risks posed by its weed killers.

It awarded $39 million in compensatory and $250 million in punitive damages.

Monsanto in a statement said it would appeal the verdict. “Today’s decision does not change the fact that more than 800 scientific studies and reviews…support the fact that glyphosate does not cause cancer, and did not cause Mr. Johnson’s cancer,” the company said.

Monsanto denies that glyphosate, the world’s most widely used herbicide, causes cancer and says decades of scientific studies have shown the chemical to be safe for human use.

Johnson’s case, filed in 2016, was fast-tracked for trial due to the severity of his non-Hodgkin’s lymphoma, a cancer of the lymph system that he alleges was caused by Roundup and Ranger Pro, another Monsanto glyphosate herbicide. Johnson’s doctors said he is unlikely to live past 2020.

A former pest control manager for a California county school system, Johnson, 46, applied the weed killer up to 30 times per year.

Brent Wisner, a lawyer for Johnson, in a statement said jurors for the first time had seen internal company documents “proving that Monsanto has known for decades that glyphosate and specifically Roundup could cause cancer.” He called on Monsanto to “put consumer safety first over profits.”

Over the course of the four-week trial, jurors heard testimony by statisticians, doctors, public health researchers and epidemiologists who disagreed on whether glyphosate can cause cancer.

The U.S. Environmental Protection Agency in September 2017 concluded a decades-long assessment of glyphosate risks and found the chemical not likely carcinogenic to humans. But the World Health Organization’s cancer arm in 2015 classified glyphosate as “probably carcinogenic to humans.”

About the author

Comments

  • GOOSE

    Why didn’t Monsanto use their, claimed, 800 studies to defend themselves in this lawsuit?

  • ed

    This is not very surprising as most of these products have been known to cause cancer as of a very long time ago. Most of the companies data at research time will show thrm what they already expect it will being foriegn products to a human body. What is most often being really researched is the verbal rationale that is being built to support safety on a product where safety does not exist. Can you develop a circular line of logic and doctored up studies that add a little slight of hand to the discussion. This will jam false data through a revolving door of political, bureaucratic, and scientific soap box microphone messaging as to hid in plain sight the real story to attempt to mitigate liability and maximize profits. Many people are paid above and below the table to keep the ponzi scheme going and it can work for a long period of time, but eventually it will come totally unraveled. And surprise, surprise here we are! Again!

  • Rob Bright

    You lose, Monsanto! 40 years of lying and poisoning people have got you to this point. Enough of your tobacco science and irresponsible greed. Time to pay the piper!

  • richard

    Has anyone noticed now that Monsanto’s troll room in St. Louis has been extirpated, that there is a sudden hush on these and other threads by those vainly attempting to defend the indefensible? … I’m really gonna miss the entertainment value if not the “alternative facts”

explore

Stories from our other publications